Frankfurt - Delayed Quote EUR
Arctic Bioscience AS (9TD.F)
0.3500
+0.0260
+(8.02%)
At close: April 25 at 8:02:35 AM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-40,286.4880
-40,286.4880
-25,395.3210
-39,492.9500
-21,889.3100
Investing Cash Flow
-43,103.9920
-43,103.9920
-58,565.4560
-36,503.5150
-13,432.2900
Financing Cash Flow
18,840.9760
18,840.9760
749.9920
290,758.7150
23,929.1440
End Cash Position
79,602.0690
79,602.0690
144,151.5730
227,362.3580
12,600.1080
Capital Expenditure
-45,334.0880
-45,334.0880
-58,565.4560
-36,503.5150
-13,432.2900
Issuance of Capital Stock
16,792.2460
16,792.2460
749.9920
299,209.9770
22,632.2140
Repayment of Debt
--
--
--
-6,575.5840
-582.9330
Free Cash Flow
-85,620.5760
-85,620.5760
-83,960.7770
-75,996.4650
-35,321.6000
12/31/2020 - 5/4/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade